Pancreatic Injury after COVID-19 Vaccine-A Case Report.
Artur CieślewiczMagdalena DudekIwona Krela-KaźmierczakAnna JabłeckaMaciej LesiakKatarzyna KorzeniowskaPublished in: Vaccines (2021)
The COVID-19 pandemic has caused more than 3 million deaths worldwide. Recently developed genetically engineered vaccines are the most critical solution for controlling the pandemic. Clinical trials on a large number of participants confirmed their safety and efficacy. However, with the growing number of vaccinated people, new infrequent adverse effects have been reported, not described in the medicinal product characteristics. We would like to report a case of acute pancreatic injury that occurred shortly after administering Pfizer BioNTech COVID-19 mRNA vaccine (Comirnaty). The report points out the potential need for close monitoring of patients reporting abdominal pain after vaccination (unresponsive to standard oral painkillers) because such symptom can be associated with acute pancreatitis.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- clinical trial
- abdominal pain
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- liver failure
- emergency department
- patient reported
- respiratory failure
- intensive care unit
- randomized controlled trial
- binding protein
- patient reported outcomes
- risk assessment
- extracorporeal membrane oxygenation
- human health
- adverse drug
- electronic health record
- acute respiratory distress syndrome
- phase iii
- double blind
- study protocol
- mechanical ventilation